The framework predicts how proteins will function with several interacting mutations and finds combinations that work well together.

Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery for membrane proteins, today announced a scientific ...

Artificial intelligence (AI) is transforming how scientists understand proteins—these are working molecules that drive nearly every process in the human body, from cell growth and immune defense to ...

A computational biology company that started in space tech is looking to change how biopharma finds disease targets by ...

Artificial intelligence isn’t just changing how we search the web or generate images. It is reshaping how scientists approach one of biology’s oldest problems: the folding of proteins. Google DeepMind ...

Accessible to all, millions of scientists, doctors, researchers and students around the world access the RCSB PDB annually. The RCSB PDB Molecule of the Month presents short accounts on selected ...

Your gut harbors trillions of microbes which live in precarious harmony with your immune system. When that harmony is upset, the results can be excruciating—especially for those with Crohn’s disease, ...

Integrative modeling transforms how scientists understand molecular machines, with Rutgers researchers leading the global effort The Research Collaboratory for Structural Bioinformatics Protein Data ...

TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of ...